XML 37 R26.htm IDEA: XBRL DOCUMENT v3.23.1
Liquidity (Narrative) (Details)
3 Months Ended
Jan. 10, 2023
USD ($)
$ / shares
Mar. 31, 2022
USD ($)
shares
Feb. 09, 2022
USD ($)
tranche
$ / shares
shares
Mar. 31, 2023
USD ($)
$ / shares
Dec. 31, 2022
USD ($)
$ / shares
Liquidity, management evaluation       The Company has prepared its condensed consolidated financial statements on a going concern basis, which assumes that the Company will realize its assets and satisfy its liabilities in the normal course of business. However, the Company has incurred net losses since its inception and has negative operating cash flows. These circumstances raise substantial doubt about the Company’s ability to continue as a going concern. The accompanying condensed consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the outcome of the uncertainty concerning the Company’s ability to continue as a going concern.  
Cash and cash equivalents | $   $ 46,408,000   $ 25,106,000 $ 14,852,000
Common stock, par value (in dollars per share) | $ / shares       $ 0.01 $ 0.01
Innoviva Strategic Opportunities LLC [Member] | Secured term loan          
Aggregate amount | $ $ 30,000,000        
Interest rate (as a percent) 8.00%        
Common stock, par value (in dollars per share) | $ / shares $ 0.01        
Discount on share price for conversion 15.00%        
Price per share | $ / shares $ 1.52        
Innoviva Strategic Opportunities LLC [Member] | Secured term loan | Minimum [Member]          
Discount on share price for conversion 15.00%        
Securities Purchase Agreement [Member] | Innoviva Strategic Opportunities LLC [Member]          
Number of tranches | tranche     2    
Shares Issued, Price Per Share | $ / shares     $ 5.00    
Stock Issued During Period, Shares, New Issues     9,000,000    
Class of Warrant or Right, Number of Securities Called by Warrants or Rights     4,500,000    
Exercise price of warrants | $ / shares     $ 5.00    
Securities Purchase Agreement First Tranche [Member] | Innoviva Strategic Opportunities LLC [Member]          
Stock Issued During Period, Shares, New Issues     3,614,792    
Class of Warrant or Right, Number of Securities Called by Warrants or Rights     1,807,396    
Proceeds from issuance of common stock and warrants | $     $ 18,100,000    
Securities Purchase Agreement Second Tranche [Member] | Innoviva Strategic Opportunities LLC [Member]          
Stock Issued During Period, Shares, New Issues   5,385,208      
Class of Warrant or Right, Number of Securities Called by Warrants or Rights   2,692,604      
Proceeds from issuance of common stock and warrants | $   $ 26,900,000